3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
20
Carcinoma, Non-Small-Cell Lung
20
Carcinoma, Hepatocellular
15
Brain Neoplasms
12
Breast Neoplasms
10
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Lung Neoplasms
5
Neoplasms
4
Recurrence
3
Colorectal Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroma, Acoustic
2
NSCLC
2
Liver Neoplasms
2
Head and Neck Neoplasms
2
Glioblastoma
2
Esophageal Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
1
Stage IA - IB Non Small Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Spine Metastasis
1
Spinal Neoplasms
1
Spinal Bone Metastases
1
Solid Tumor
1
Sarcoma
1
Rare Diseases
1
Radiotherapy
1
Interventions
Serum Albumin, Human
1
Radiosurgery
1
Polygeline
1
Pancreaticoduodenectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pancreatic Fistula
×
Radiosurgery
×
Clear all
NCT05641233
2022-12-07
FIBROPANC-1
Erasmus Medical Center
Phase 1/2
Unknown
33 enrolled